Filtros de búsqueda

Lista de obras de

Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial

scientific article published on 13 August 2018

Erratum: preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

artículo científico publicado en 2015

European perspective for effective cancer drug development

artículo científico publicado en 2014

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN

artículo científico publicado en 2020

International clinical trials setting for rare cancers: organisational and regulatory constraints-the EORTC perspective.

artículo científico publicado en 2013

Lomustine and Bevacizumab in Progressive Glioblastoma

artículo científico publicado en 2017

NIMG-75. NECROSIS DURING TREATMENT IS ASSOCIATED WITH WORSE SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS – POST HOC IMAGE ANALYSIS OF EORTC 26101

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082).

artículo científico publicado en 2016

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study

artículo científico publicado en 2013

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

artículo científico publicado en 2017

The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeutics

artículo científico publicado en 2016

The dream and reality of histology agnostic cancer clinical trials

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda